Shares Outstanding
Total shares outstanding over time.
Latest Shares Outstanding: $2,409,295,102.00 (2025Q3); +0.1% YoY; -0.8% CAGR since 2009Q2 (16.25y).
Chart and table show the latest 24 of 50 quarters.
Revenue
EPS
Free Cash Flow
Gross Margin
FCF Margin
P/E Ratio
Cumulative FCF
Shares Outstanding
Rule of 40
Quarterly Shares Outstanding Data
Chart and table show the latest 24 of 50 quarters.
| Period | Value |
|---|---|
| 2018Q1 | $2,682,149,964.00 |
| 2018Q2 | $2,682,756,061.00 |
| 2018Q3 | $2,681,977,969.00 |
| 2019Q1 | $2,655,055,987.00 |
| 2019Q2 | $2,639,165,527.00 |
| 2019Q3 | $2,631,872,399.00 |
| 2020Q1 | $2,634,594,535.00 |
| 2020Q2 | $2,632,823,475.00 |
| 2020Q3 | $2,632,542,672.00 |
| 2021Q1 | $2,633,396,003.00 |
| 2021Q2 | $2,632,482,092.00 |
| 2021Q3 | $2,632,596,969.00 |
| 2022Q1 | $2,631,401,804.00 |
| 2022Q2 | $2,629,179,895.00 |
| 2022Q3 | $2,614,483,607.00 |
| 2023Q1 | $2,598,734,075.00 |
| 2023Q2 | $2,598,969,594.00 |
| 2023Q3 | $2,407,278,620.00 |
| 2024Q1 | $2,406,679,183.00 |
| 2024Q2 | $2,407,243,667.00 |
| 2024Q3 | $2,407,622,972.00 |
| 2025Q1 | $2,406,073,279.00 |
| 2025Q2 | $2,408,338,872.00 |
| 2025Q3 | $2,409,295,102.00 |
Healthcare Comparison
1 / 3
Other JNJ Charts
More quarter-by-quarter fundamentals for Johnson & Johnson
1 / 8